Researches reported that obese women are less likely than thin females to be screened for breast and cervical cancers.

The virus responsible for most cases of cervical cancer has a serious weakness which may provide hope for new treatments for the disease.

A significant drop in abnormal Pap test results happened after girls and women were given a vaccine to prevent cervical cancer, according to a researcher at the University of Alabama at Birmingham (UAB).

The Swedish Social Welfare Board has decided that a vaccine which helps prevent cervical cancer will be included in the series of vaccinations given to girls.

A new study showed that stress can lead to the development of cervical cancer in women. The recent study published in the February issue of Annals of Behavioral Medicine, examined 78 women who were diagnosed with cervical dysplasia (precancerous cervical lesions).

Swedish Radio News reports that family wealth seems to determine which girls receive a vaccine that reduces the risk of some forms of cancer.

For the first time researchers from Pennsylvania State University College of Medicine suggest a direct interaction between cigarette smoke carcinogens and the human papillomavirus that may lead to increased risk of cervical cancer. They report their findings in the January 2008 issue of the Journal of Virology.

A new study has estimated the costs of providing comprehensive screening and diagnostic services to under-or uninsured, low-income women to identify those with breast or cervical cancer for treatment.

According to a report issued last week by UNAIDS, access to antiretroviral therapy is beginning to reduce AIDS mortality worldwide. But Dr. Groesbeck Parham, gynecologic oncologist and Director of the Cervical Cancer Prevention Program at the Center for Infectious Disease Research in Zambia (CIDRZ) warns that women being treated for AIDS could end up dying of cervical cancer unless they have access to screening and treatment.

Scientists discovered that women taking the birth control pill had a slightly higher risk of cervical cancer. But that risk disappears a decade after they stop taking it.

Iowa State University researchers have developed a technology that detects a single molecule of the virus associated with cervical cancer in women.

Women are still at risk of developing invasive cancer of the cervix or vagina 25 years after being treated for pre-cancerous lesions, according to a study published today on bmj.com.